Clinical Trials · NCT03902951
Antiandrogen Therapy and SBRT in Treating Patients With Recurrent, Metastatic Prostate Cancer
- Phase
- Phase 2
- Recruitment status
- Active Not Recruiting
- Sponsor
- Jonsson Comprehensive Cancer Center
- Enrollment
- 28
- Start date
- Mar 2021
- Locations
- 1 site, United States
- Primary endpoint
- Percent of patients achieving a serum prostate specific antigen (PSA) of < 0.05 ng/mL